NC
GMED icon

NinePointTwo Capital’s Globus Medical GMED Stock Holding History

NinePointTwo Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,861
Closed -$275K – 283
2023
Q1 		$275K Buy
+4,861
New +$312K 0.1% 62

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

NinePointTwo Capital's GMED Position: Q2 2023 in Review

NinePointTwo Capital sold out of Globus Medical (GMED) in Q2 2023, closing a stake of 4,861 shares — an estimated $275K sold.

NinePointTwo Capital first reported a position in GMED in Q1 2023 and held it in 1 quarter. The position peaked at $275K in Q1 2023. 382 funds tracked by Wall St. Rank hold GMED as of Q2 2023.

  • NinePointTwo Capital reported no remaining Globus Medical position as of Q2 2023 after selling out during the quarter.
  • NinePointTwo Capital sold 4,861 Globus Medical shares in Q2 2023, an estimated $275K.
  • NinePointTwo Capital first reported a position in Globus Medical in Q1 2023 and held it in 1 quarter.
  • NinePointTwo Capital's Globus Medical position peaked at $275K in Q1 2023.
  • 382 funds tracked by Wall St. Rank held Globus Medical as of Q2 2023.

Based on NinePointTwo Capital's 13F filing for Q2 2023, filed 14 Aug 2023.